Authors


Lewis B. Morgenstern, MD

Latest:

Targeting High-Risk Employees May Reduce Cardiovascular Racial Disparities

Targeting cardiovascular risk reduction interventions to high-risk patients has the potential to reduce cardiovascular racial disparities, improve health, and reduce costs.


Anna N. A. Tosteson, ScD

Latest:

Alignment of Breast Cancer Screening Guidelines, Accountability Metrics, and Practice Patterns

This study measured breast cancer screening practice patterns in relation to evidence-based guidelines and accountability metrics, and found closer alignment is needed for providing patient-centered care.


Midge N. Ray, PhD

Latest:

Association of Part D Coverage Gap With COPD Medication Adherence

Using longitudinal Medicare claims data, this study quantified the association of the Medicare Part D coverage gap with medication adherence among beneficiaries with chronic obstructive pulmonary disease.


Davide Radice, PhD

Latest:

Does a Personalized Approach Improve Patient Satisfaction in Thoracic Oncology?

Evaluation of cancer patients’ quality of life at admission enabled improvement of their satisfaction with received care at discharge.


Jose Villagra, BS

Latest:

A Cost-Effectiveness Analysis of Cardiology eConsults for Medicaid Patients

A randomized trial of eConsults for cardiology referrals from primary care resulted in significant reductions in total cost of care compared with traditional face-to-face consultations.





Winfred Frazier, MD

Latest:

Medicaid Prior Authorization and Opioid Medication Abuse and Overdose

Enrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.




Diane Feeney Mahoney, PhD, APRN, BC, FGSA, FAAN

Latest:

"Under the Radar": Nurse Practitioner Prescribers and Pharmaceutical Industry Promotions

Nurse practitioner prescribers exhibited a high rate of contact with pharmaceutical industry promotional activities.



Danielle Bonadies, CGC, MS

Latest:

Forward-Thinking Insurers Adopt Genomics, Medicare Makes Perilous, Costly Leap Backward

Authors from My Gene Counsel discuss gaps in CMS reimbursement policy for genetic testing and counseling, in light of advances in guidelines from groups that include the National Comprehensive Cancer Network.



Elizabeth Richardson, MSc

Latest:

Value-Based Arrangements May Be More Prevalent Than Assumed

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.








Grace Wong, MBA, MPH

Latest:

Emergency Department Use: A Reflection of Poor Primary Care Access?

An original emergency department patient survey, insurance claims data, and administrative records are used to examine the characteristics of nonurgent users.





Yang Qiu, MS

Latest:

Sofosbuvir Initial Therapy Abandonment and Manufacturer Coupons in a Commercially Insured Population

Member cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.



Serena Roth, MD

Latest:

Unintended Consequences of a Quality Measure for Acute Bronchitis

A quality measure reduced antibiotic use for patients with acute bronchitis but led to use of an alternative diagnosis, offsetting most of the observed improvement.


J. Nwando Olayiwola, MD, MPH

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo